OSUR — OraSure Technologies Share News
0.000.00%
Last trade - 00:00- $262.77m
- $102.39m
- $115.02m
OraSure Q2 revenue rises on higher diagnostics sales
Brief: OraSure Technologies Q2 Revenue USD 30.6 Million
OraSure Technologies Inc expected to post a loss of 27 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Wabtec, Chubb, CME Group
U.S. STOCKS ON THE MOVE-Wabtec, Johnson & Johnson, CME Group
U.S. STOCKS ON THE MOVE-GE Vernova, Arrowhead Pharma
U.S. STOCKS ON THE MOVE-AT&T, Cal-Maine Foods, OraSure Technologies
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
OraSure rises after Bundibugyo Ebola test receives US FDA emergency use nod
Brief: Orasure Receives Emergency Use Authorization For Second Generation Ebola Test
OraSure Technologies Q1 revenue declines on lower HCV test sales
Brief: OraSure Technologies Q1 Revenue USD 27.9 Million
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
-Altai Capital presses OraSure to sell and give it board seats, letter says (updated)
Brief: Orasure Highlights Significant Operational Progress Following Letter from Altai Capital
Altai Capital presses OraSure to sell and give it board seats, letter says
OraSure Q4 revenue falls 29%, core business down 22%